Gut Microbiome

Integrated multi-omics analysis unveils microbiota-metabolite-host interactions and novel biomarkers for early diabetic kidney disease diagnosis.

TL;DR

Multi-omics integration combined with machine learning identified microbiota-metabolite interactions and achieved over 90% accuracy in distinguishing T2DM from DKD in an East Asian cohort, suggesting candidate biomarkers for early DKD detection.

Key Findings

Mendelian randomization analysis identified significant associations between specific microbiota taxa and DKD in an East Asian cohort.

  • MR analysis examined more than 190 microbiota taxa in relation to DKD within the East Asian cohort.
  • Specific taxa identified with significant associations included Haemophilus-A, TM7x, Lachnoanaerobaculum, and Bacteroides.
  • The authors note that 'the causal nature of these associations requires further experimental or longitudinal validation.'
  • The analysis was population-specific, focusing on East Asian individuals who are characterized by 'distinct genetic, environmental, and lifestyle factors.'

Mendelian randomization analysis identified significant associations between specific metabolites, including tyrosine and glutamine, and DKD in an East Asian cohort.

  • MR analysis examined 404 differential metabolites in relation to DKD.
  • Tyrosine and glutamine were among the metabolites identified with significant associations to DKD.
  • Causal nature of these metabolite associations also requires further experimental or longitudinal validation per the authors.

Clinical analysis revealed microbial dysbiosis in DKD patients, including a 2.5-fold increase in Klebsiella and a 60% reduction in Faecalibaculum and Dubosiella.

  • Clinical samples were collected from n=535 East Asian individuals and analyzed for microbiota composition.
  • Klebsiella showed a 2.5-fold increase in DKD patients compared to T2DM patients.
  • Faecalibaculum and Dubosiella each showed a 60% reduction in DKD patients.
  • These findings characterize microbial dysbiosis specific to DKD progression in this East Asian cohort.

Metabolomic profiling of DKD patients demonstrated alterations in branched-chain amino acids (BCAAs) and fatty acids.

  • Metabolomic profiling was performed on clinical samples from n=535 East Asian individuals.
  • Alterations were found specifically in branched-chain amino acids (BCAAs) and fatty acids in DKD patients.
  • Integrated multi-omics analysis suggested 'complex interactions among microbiota and metabolites that may contribute to DKD progression.'

Machine learning models achieved an accuracy exceeding 90% in distinguishing T2DM from DKD in the East Asian cohort.

  • ML models were constructed using data from n=535 clinical samples including microbiota composition, metabolomic profiling, and tongue image features (TIFs).
  • The ML models achieved 'an accuracy exceeding 90% in distinguishing T2DM from DKD in the East Asian cohort.'
  • Tongue image features (TIFs) were included as a non-invasive input feature alongside microbiota and metabolomic data.
  • The models were designed to support non-invasive diagnosis and personalized management strategies.

Tongue image features (TIFs) were incorporated alongside microbiota composition and metabolomic profiles as analytical inputs for DKD differentiation.

  • Clinical samples (n=535) were analyzed for microbiota composition, metabolomic profiling, and TIFs.
  • TIFs represent a non-invasive data modality integrated into the multi-omics framework.
  • This combination was used to develop ML models distinguishing T2DM from DKD patients.

The study focused specifically on an East Asian population to address population-specific factors influencing DKD development and progression.

  • The East Asian population is characterized by 'distinct genetic, environmental, and lifestyle factors that may influence the development and progression of DKD.'
  • The authors emphasize 'the importance of population-specific research' for this condition.
  • A total of n=535 clinical samples were collected from East Asian individuals.
  • Conventional biomarkers for DKD 'lack sensitivity,' motivating the development of population-specific multi-omics approaches.

Have a question about this study?

Citation

Jiang T, Deng J, Hu X, Yao D, Chen Q, Hu R, et al.. (2026). Integrated multi-omics analysis unveils microbiota-metabolite-host interactions and novel biomarkers for early diabetic kidney disease diagnosis.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1781013